x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DMM-001147
| Status | Age | Sex |
|---|---|---|
|
|
|
| Product Overview | |
|---|---|
| Model Description | A 0.6kb region in length including Mir29a and Mir29b-1 pre-microRNAs was removed in this strain. |
| Strain Name | C57BL/6J-Mir29aem1 Mir29b-1em1 |
| Background Strain | C57BL/6J |
| SPF | Yes |
| Research Application | The microRNA; mir29 gene function study. |
| Target Information | |
|---|---|
| Target Name | Mir29a, Mir29b1 |
| Synonyms | Mirn29a mir-29a mmu-mir-29a,|Mirn29b Mirn29b-1 mir-29b-1 |
| Gene ID | 387222, 387223 |
Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
